TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
IMCR

Immunocore Holdings Ltd

Healthcare · Biotechnology

29.90$ -1.8% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns Immunocore Holdings Ltd (IMCR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 89.3% of the shares are freely tradable; institutional investors hold 101.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 101.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 89.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 16.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 52Mio.

Largest Shareholders

Institutions

Institutions IMCR
Name Stake (%) Shares Change (%) Date
Wellington Management Company LLP 11.11 5,721,945 +21.6 06/30/2026
RTW INVESTMENTS, LLC 9.46 4,869,798 +0.0 06/30/2026
FMR Inc 8.36 4,307,246 -10.8 06/30/2026
PRIMECAP Management Company 7.06 3,638,241 -1.5 06/30/2026
Bellevue Group AG 5.41 2,788,245 -0.3 06/30/2026
TANG CAPITAL MANAGEMENT LLC 5.14 2,649,368 +0.0 06/30/2026
Vestal Point Capital LP 3.50 1,800,000 -34.9 06/30/2026
Two Sigma Investments LLC 3.20 1,648,983 +61.5 06/30/2026

Funds

Funds IMCR
Name Stake (%) Shares Change (%) Date
Vanguard Health Care Inv 8.25 4,246,274 +0.0 09/30/2026
Vanguard Capital Opportunity Inv 4.54 2,335,650 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?